Hepatitis B virus and hepatocellular carcinoma: antiviral therapy and risk estimation
2012
The incidence of hepatocellular carcinoma is increasing year by year all over the world.Hepatoma has become one of the main causes of cancer-related death.For many years,studies found the chronic hepatitis B virus infection is the leading cause of hepatocellular carcinoma,and antiviral therapy for hepatitis B virus could obviously reduce the incidence of hepatoma and prevent recurrence after hepatectomy.Making appropriate risk estimation in patients with chronic hepatitis B and providing patients with high risk the effective medical intervention can help to prevent the occurrence and delay the development of hepatocellular carcinoma.
Key words:
Hepatitis B virus; Carcinoma, hepatocellular; Antiviral therapy; Risk estimation
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI